Title: LAMEA Anti-cancer Drugs Market: growth in testicular cancer treatment and drugs in future
1LAMEA Oncology/Anti-cancer drugs Market -
Opportunities and Forecasts, 2014 - 2021
Published on 1 February, 2016 Number of pages
108 Single User Price 2580
The research methodology used to estimate and
forecast LAMEA Oncology/Anti-cancer drugs Market
begins with capturing data on key vendor revenue
through the secondary research.
2Summary of the Report The Oncology or anti -
cancer drugs are the drugs that are often used
for the treatment of the cancer patients. Some of
the common cancers that are rampant currently are
prostate cancer, ovarian cancer, testicular
cancer, adenocarcinoma, pancreatic cancer, colon
cancer etc. The LAMEA Oncology/Anti-cancer Drugs
Market deals with the production, supply and
distribution along with scope and demand in the
LAMEA region during 2014-2021.
Click Here To Check Complete Report
3Topics Covered in this report Scope of the
LAMEA Oncology/Anti-cancer Drugs Market The
LAMEA Oncology/Anti-cancer Drugs Market is
expected to reach 17,072.2 million by 2021. The
rising cases of cancer, increasing investment by
the government for research and development,
capital expenditure by drug companies to develop
drugs are the major factors driving this market
during 2014-2021. Anti - cancer drugs patent
expiration of Herceptin (Patent Expiration
EU-2014 US-2019), Erbitux (Patent Expiration
EU-2014 US-2016), Rituxan (Patent Expiration
EU-2013 US-2018) and Avastin (Patent Expiration
EU-2018 US-2019) is expected to boost the
production and supply growth of the LAMEA
Oncology/Anti-cancer Drugs Market in LAMEA.
4In the LAMEA Oncology/Anti-cancer Drugs Market,
the biological therapy is expected to grow at a
CAGR of 12.2 by 2021, whereas the blood cancer
drugs are the largest segment to generate
revenues during 2015. Brazil dominated this
market with high investment and sales, closely
followed by Argentina. LAMEA is poised to grow at
a CAGR of 8.6 in this market during
2014-2021. Segmentation and Key Players of the
LAMEA Oncology/Anti-cancer Drugs Market The
LAMEA Oncology/Anti-cancer Drugs Market is
segmented into various categories by therapeutic
modalities, by cancer type and by country as
follows
5By therapeutic modalities Chemotherapy, Targeted
Therapy, Immunotherapy (Biologic Therapy),
Hormonal Therapy and others By cancer type
Blood Cancer, Breast Cancer, Gastrointestinal
Cancer, Respiratory/Lung Cancer, Skin Cancer and
other Cancers By country Brazil, Argentina,
Nigeria, South Africa, Iraq, Iran, Algeria, Saudi
Arabia and Egypt
Download Sample Brochure
6- The key players in the LAMEA Oncology/Anti-cancer
Drugs Market are as follows - AstraZeneca Plc.
- Roche Diagnostics
- Sanofi
- Novartis
- GlaxoSmithKline PLC
-
- The LAMEA Oncology/Anti-cancer Drugs Market is a
rapidly growing market due to increasing cases of
various cancer types in the population of the
LAMEA region. This market is expected to witness
high growth owing to increasing RD investment by
medical corporations, growing cases of cancer
such as liver cancer, thyroid cancer, stomach
cancer, bone cancer and others, affordability of
cancer drugs and many others in the LAMEA region
during 2014-2021.
Inquiry Before Buying
7LAMEA Oncology/Anti-cancer drugs Market -
Opportunities and Forecasts, 2014 - 2021
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the LAMEA Oncology/Anti-cancer drugs Market and
future opportunities are provided in the report.
Contact 1-302-261-5343 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of LAMEA
Oncology/Anti-cancer drugs Market 2014-2021
Research Report